Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2012 | 09-2011 | 09-2010 | |
| Cash Flows From Operating Activities | |||
| Net Income | 28,952 | 23,310 | 7,900 |
| Depreciation Amortization | 224 | 810 | 550 |
| Accounts receivable | 176 | N/A | N/A |
| Accounts payable and accrued liabilities | -117 | N/A | N/A |
| Other Working Capital | -1,044 | -2,400 | -18,410 |
| Other Operating Activity | -38 | 2,290 | -210 |
| Operating Cash Flow | $28,153 | $24,010 | $-10,170 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -36 | -430 | -30 |
| Purchase Of Investment | -29,549 | N/A | N/A |
| Sale Of Investment | 14,050 | N/A | N/A |
| Other Investing Activity | 1,140 | -17,250 | 1,690 |
| Investing Cash Flow | $-14,395 | $-17,680 | $1,660 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 107 | N/A | N/A |
| Other Financing Activity | 0 | 30 | 8 |
| Financing Cash Flow | $107 | $30 | $8 |
| Beginning Cash Position | 6,837 | 460 | 8,970 |
| End Cash Position | 20,702 | 6,830 | 460 |
| Net Cash Flow | $13,865 | $6,370 | $-8,500 |
| Free Cash Flow | |||
| Operating Cash Flow | 28,153 | 24,010 | -10,170 |
| Capital Expenditure | -94 | N/A | N/A |
| Free Cash Flow | 28,059 | 24,010 | -10,170 |